Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...
2don MSN
Weight loss drugs like Ozempic deliver more health benefits than expected.
Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...
"Studies have shown benefits in worsening kidney disease, heart failure and obstructive ... effect of a gaunt face (colloquially called "Ozempic face"), particularly in patients with less skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results